Study of Apoptosis Induced by 188Re-DTPA-DG in MCF-7 Breast Carcinoma and A549 Pulmonary Carcinoma Cells-Reference-Cited by-同舟云学术

Study of Apoptosis Induced by 188Re-DTPA-DG in MCF-7 Breast Carcinoma and A549 Pulmonary Carcinoma Cells

Published:2007-08 Issue:4 Volume:22 Page:543-550
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Xiong Qing-Feng¹,Chen Yue¹,He Ling²,Deng Cun-Liang³,Huang Zhan-Wen¹,Li Ju-Lian²

Affiliation:

1. Department of Nuclear Medicine, Affiliated Hospital of Luzhou Medical College, Luzhou, China

2. West China School of Pharmacy, Sichuan University, Chengdu, Sichuan, China

3. Department of Infection, Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan, China

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2007.367A

Reference15 articles.

1. Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb188Re-HAb18

2. Preparation, biodistribution, and dosimetry of 188Re-Labeled MoAb ior cea1 and its f(ab′)2 fragments by avidin-biotin strategy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preliminary Studies of 177Lu-Diethylenetriamine Penta-Acetic Acid-Deoxyglucose in Hepatic Tumor-Bearing Mice;Cancer Biotherapy and Radiopharmaceuticals;2020-02-01

2. 18F-FDG and Other Labeled Glucose Derivatives for Use in Radionuclide Diagnosis of Oncological Diseases (Review);Pharmaceutical Chemistry Journal;2016-08

3. In vitro evaluation of apoptosis with 99mTc-glucoheptonate;Applied Radiation and Isotopes;2011-07

4. Evaluation of 188Re-DTPA-Deoxyglucose as a Potential Cancer Radiopharmaceutical;American Journal of Roentgenology;2010-03

5. Cancer Drug Development Using Glucose Metabolism Radiopharmaceuticals;Current Pharmaceutical Design;2009-03-01